Farallon Capital Management’s Hims & Hers Health HIMS Stock Holding History

Farallon Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$208K	–	133
2026 Q1	$208K	Sell	10,000 -3,376,986	-100%	-$79.8M	﹤0.01%	142
2025 Q4	$110M	Sell	3,386,986 -7,359,866	-68%	-$315M	0.48%	46
2025 Q3	$610M	Buy	10,746,852 +2,533,271	+31%	+$130M	2.5%	12
2025 Q2	$409M	Buy	8,213,581 +259,876	+3%	+$11.7M	1.72%	24
2025 Q1	$235M	Sell	7,953,705 -423,295	-5%	-$15.7M	1.13%	36
2024 Q4	$203M	Buy	8,377,000 +8,364,000	+64,338%	+$207M	0.89%	40
2024 Q3	$239K	Buy	13,000 +3,000	+30%	+$53.7K	﹤0.01%	132
2024 Q2	$202K	Sell	10,000 -1,666,000	-99%	-$27.7M	﹤0.01%	138
2024 Q1	$25.9M	Buy	1,676,000 +1,634,000	+3,890%	+$18.4M	0.11%	65
2023 Q4	$374K	Hold	42,000	–	–	﹤0.01%	115
2023 Q3	$264K	Buy	+42,000	New	+$312K	﹤0.01%	124

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management's HIMS Position: Q2 2026 in Review

Farallon Capital Management sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 10,000 shares — an estimated $208K sold.

Farallon Capital Management first reported a position in HIMS in Q3 2023 and held it in 11 quarters. The position peaked at $610M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Farallon Capital Management reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
Farallon Capital Management sold 10,000 Hims & Hers Health shares in Q2 2026, an estimated $208K.
Farallon Capital Management first reported a position in Hims & Hers Health in Q3 2023 and held it in 11 quarters.
Farallon Capital Management's Hims & Hers Health position peaked at $610M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.